Literature DB >> 8057488

The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo.

H Kollmus1, A Honigman, A Panet, H Hauser.   

Abstract

We have analyzed in cell culture the sequence elements that control the level of ribosomal frameshifting in the human T-cell leukemia virus type II (HTLV-2) gag-pro junction. The slippery sequence of HTLV-2 is sufficient to dictate a basal level of frameshifting. This level is enhanced by its upstream sequence context and by the downstream stem-loop structure which is located at an optimal distance of 7 bases. Frameshifting in human immunodeficiency virus gag-pol is similar to that of HTLV-2 gag-pro. However, experiments using hybrid cassettes of HTLV-2 and human immunodeficiency virus type 1 frameshift elements show that while the slippery sequence of HTLV-2 is less efficient, the stem-loop structure is a more efficient enhancer.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8057488      PMCID： PMC237019     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  22 in total

1.  Intermediate states in the movement of transfer RNA in the ribosome.

Authors:  D Moazed; H F Noller
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

2.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.

Authors:  W Wilson; M Braddock; S E Adams; P D Rathjen; S M Kingsman; A J Kingsman
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

4.  Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

5.  Translation of gag, pro, and pol gene products of human T-cell leukemia virus type 2.

Authors:  N Mador; A Panet; A Honigman
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

7.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

8.  A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells.

Authors:  H Reil; H Kollmus; U H Weidle; H Hauser
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

10.  A novel programed frameshift expresses the POL3 gene of retrotransposon Ty3 of yeast: frameshifting without tRNA slippage.

Authors:  P J Farabaugh; H Zhao; A Vimaladithan
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582
View more
  39 in total

1.  The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure.

Authors:  Jonathan D Dinman; Sara Richter; Ewan P Plant; Ronald C Taylor; Amy B Hammell; Tariq M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 2.  P-site tRNA is a crucial initiator of ribosomal frameshifting.

Authors:  Pavel V Baranov; Raymond F Gesteland; John F Atkins
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

Review 3.  The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting.

Authors:  Ewan P Plant; Kristi L Muldoon Jacobs; Jason W Harger; Arturas Meskauskas; Jonathan L Jacobs; Jennifer L Baxter; Alexey N Petrov; Jonathan D Dinman
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

4.  A -1 ribosomal frameshift element that requires base pairing across four kilobases suggests a mechanism of regulating ribosome and replicase traffic on a viral RNA.

Authors:  Jennifer K Barry; W Allen Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

5.  Identification of a cellular factor that modulates HIV-1 programmed ribosomal frameshifting.

Authors:  Yoshifumi Kobayashi; Jianling Zhuang; Stuart Peltz; Joseph Dougherty
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

6.  Stimulation of -1 programmed ribosomal frameshifting by a metabolite-responsive RNA pseudoknot.

Authors:  Ming-Yuan Chou; Szu-Chieh Lin; Kung-Yao Chang
Journal:  RNA       Date:  2010-04-30       Impact factor: 4.942

Review 7.  The role of programmed-1 ribosomal frameshifting in coronavirus propagation.

Authors:  Ewan P Plant; Jonathan D Dinman
Journal:  Front Biosci       Date:  2008-05-01

8.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  The interplay of mRNA stimulatory signals required for AUU-mediated initiation and programmed -1 ribosomal frameshifting in decoding of transposable element IS911.

Authors:  Marie-Françoise Prère; Isabelle Canal; Norma M Wills; John F Atkins; Olivier Fayet
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

10.  Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides.

Authors:  Michael T Howard; Raymond F Gesteland; John F Atkins
Journal:  RNA       Date:  2004-10       Impact factor: 4.942
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.